October 25th, 2007 -- Genaera Corporation (NASDAQ: GENR) is providing the following summary of highlights related to the successful first Phase 1 study of trodusquemine and additional preclinical data expanding the support for selectivity and specificity of the drug in preclinical models from the North American Association for the Study of Obesity (NAASO) Annual Meeting in New Orleans... Genaera's Press Release -Monday, October 29, 2007
Genaera, Positive Phase 1 Trodusquemine (MSI-1436)
October 25th, 2007 -- Genaera Corporation (NASDAQ: GENR) is providing the following summary of highlights related to the successful first Phase 1 study of trodusquemine and additional preclinical data expanding the support for selectivity and specificity of the drug in preclinical models from the North American Association for the Study of Obesity (NAASO) Annual Meeting in New Orleans... Genaera's Press Release -
